FDA Approved: QUETIAPINE EXTENDED-RELEASE — Supplemental Application (AlignScience Pharma Inc.)

View source ↗

Summary

FDA approved AlignScience Pharma Inc.'s supplemental application for quetiapine extended-release, enabling its marketing as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine Extended-Release (quetiapine extended-release)

Snippet

SUPPL AP for QUETIAPINE EXTENDED-RELEASE (QUETIAPINE)